Centre Hospitalier Henri Laborit
Poitiers, France
Location status: Recruiting
Location contact
Ghina Harika Germaneau
CONTACT
NCT Number: NCT06017713
This is a single-center study about patients with severe resistant OCD.
Main assumption is that performing 10 tDCS sessions with the anode positioned at the level of the right orbitofrontal cortex, and the cathode at the level of the supplementary motor area, associated with the provocation of symptoms before each session is effective in the reduction in obsessive-compulsive symptoms.
After the inclusion visit, the treatment period is provided from D1 to D12 (one session per day from Monday to Friday, for two consecutive weeks, i.e. a total of ten sessions). Each tDCS session lasts 30 minutes at an intensity of 2 mA and is preceded by symptom provocation using a standardized procedure performed by trained personnel.
The patients are then assessed on D42 and D102 (i.e. 1 month and 3 months after the end of the tDCS sessions).
Interested in participating?
Request Info18 year–70 year
All sexes
Interventional
Not applicable
Poitiers, France
Location status: Recruiting
Ghina Harika Germaneau
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Generalized anxiety disorder, social phobia, nicotine addiction and history of major depressive episodes are not exclusion criteria. Axis I comorbidity will be explored using MINI 5.0.0. ;
The treatment consists of 10 sessions of tDCS. Each tDCS session lasts 30 minutes at an intensity of 2mA and is preceded by a provocation of symptoms.
Time frame: 3,5 months
The primary endpoint corresponds to the change in the score on the YBOCS scale between the inclusion visit (Day 0) and the Day 42 visit.
A score of 0 corresponds to the absence of OCD and a score of 40 to maximum severity.
Contact information is provided by the study sponsor or research team.
Centre Hospitalier Henri Laborit
Other
Direct Transcranial Stimulation With Direct Current Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive
Acronym: PPSTDCS-TOC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07347405
Anxiety Disorders, Mental Disorders
Tucson, Arizona, United States
View Trial DetailsNCT07701616
Anxiety Disorders, Mental Disorders
Changsha, Hunan, China
View Trial DetailsNCT06376734
Anxiety Disorders, Behavior
Sunnyvale, California, United States
View Trial DetailsNCT07704632
Anxiety Disorders, Mental Disorders
Toronto, Ontario, Canada
View Trial Details